Breast Cancer-Targets and Therapy

Papers
(The TQCC of Breast Cancer-Targets and Therapy is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
<p>Resistance and Overcoming Resistance in Breast Cancer</p>45
Treatment Strategies Against Triple-Negative Breast Cancer: An Updated Review36
A Review of Modifiable Risk Factors in Young Women for the Prevention of Breast Cancer35
Polyethyleneimine (PEI) as a Polymer-Based Co-Delivery System for Breast Cancer Therapy20
Mangifera indica (Mango): A Promising Medicinal Plant for Breast Cancer Therapy and Understanding Its Potential Mechanisms of Action20
Micropapillary Breast Carcinoma: From Molecular Pathogenesis to Prognosis20
Antiproliferation Activity and Apoptotic Mechanism of Soursop (Annona muricata L.) Leaves Extract and Fractions on MCF7 Breast Cancer Cells20
<p>Knowledge, Attitude and Practice Around Breast Cancer and Mammography Screening Among Jordanian Women</p>18
Breast Cancer: An Overview of Current Therapeutic Strategies, Challenge, and Perspectives17
Potentiating the Cytotoxic Activity of a Novel Simvastatin-Loaded Cubosome against Breast Cancer Cells: Insights on Dual Cell Death via Ferroptosis and Apoptosis13
Combination of Pertuzumab and Trastuzumab in the Treatment of HER2-Positive Early Breast Cancer: A Review of the Emerging Clinical Data12
Targeted Treatment for High-Risk Early-Stage Triple-Negative Breast Cancer: Spotlight on Pembrolizumab11
<p>Alpelisib in the Treatment of Breast Cancer: A Short Review on the Emerging Clinical Data</p>10
The Proper Ki-67 Cut-Off in Hormone Responsive Breast Cancer: A Monoinstitutional Analysis with Long-Term Follow-Up10
Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer10
Systematic Review of Breast-Q: A Tool to Evaluate Post-Mastectomy Breast Reconstruction10
An Update on the Molecular Pathology of Metaplastic Breast Cancer9
<p>Knowledge and Practice of Breast Self-Examination Among Young Women in Tertiary Education in Addis Ababa, Ethiopia</p>9
<p>Inhibition of Yes-Associated Protein-1 (YAP1) Enhances the Response of Invasive Breast Cancer Cells to the Standard Therapy</p>7
Profile of Trastuzumab Deruxtecan in the Management of Patients with HER2-Positive Unresectable or Metastatic Breast Cancer: An Evidence-Based Review7
HER2-Low Breast Cancer: Current Landscape and Future Prospects7
Treating Advanced Unresectable or Metastatic HER2-Positive Breast Cancer: A Spotlight on Tucatinib7
Breast Cancer Management in the Era of Covid-19; Key Issues, Contemporary Strategies, and Future Implications7
Based on BATMAN-TCM to Explore the Molecular Mechanism of Xihuang Pill Regulating Immune Function to Treat Breast Precancerous Lesions7
“Diagnostic and Prognostic Biomarkers of Luminal Breast Cancer: Where are We Now?”7
Heart Sparing Radiotherapy Techniques in Breast Cancer: A Focus on Deep Inspiration Breath Hold7
MicroRNA-223 is Associated with Resistance Towards Platinum-based Chemotherapy and Worse Prognosis in Indonesian Triple-negative Breast Cancer Patients6
<p>A Study on Clinical and Pathological Responses to Neoadjuvant Chemotherapy in Breast Carcinoma</p>6
Treatment and Survivorship Interventions to Prevent Poor Body Image Outcomes in Breast Cancer Survivors6
Genetic Influences in Breast Cancer Drug Resistance6
The Breast Tumor Microenvironment: Could Silicone Breast Implant Elicit Breast Carcinoma?6
<p>The Association of Serum Lipid Levels with Breast Cancer Risks Among Women with Breast Cancer at Felege Hiwot Comprehensive Specialized Hospital, Northwest Ethiopia</p>6
Research Progress on Molecular Subtyping and Modern Treatment of Triple-Negative Breast Cancer6
<p>Network Pharmacology-Oriented Identification of Key Proteins and Signaling Pathways Targeted by Xihuang Pill in the Treatment of Breast Cancer</p>5
Central Nervous System Metastases from Triple-Negative Breast Cancer: Current Treatments and Future Prospective5
miR-623 Targets Metalloproteinase-1 and Attenuates Extravasation of Brain Metastatic Triple-Negative Breast Cancer Cells5
Cytochrome 4Z1 Expression is Associated with Unfavorable Survival in Triple-Negative Breast Cancers5
Extreme Oncoplasty: Breast Conservation in Patients with Large, Multifocal, and Multicentric Breast Cancer5
Cancer Treatment-Induced Bone Loss: Role of Denosumab in Non-Metastatic Breast Cancer5
Development and Validation of an MRI Radiomics-Based Signature to Predict Histological Grade in Patients with Invasive Breast Cancer5
Breast Cancer Screening Practice and Associated Factors Among Women Aged 20–70 Years in Urban Settings of SNNPR, Ethiopia5
Factors Predicting Positive Sentinel Lymph Node Biopsy in Clinically Node-Negative Breast Cancer5
Young Women with Breast Cancer in Resource-Limited Settings: What We Know and What We Need to Do Better5
Effect of Chemotherapy on the Gut Microbiome of Breast Cancer Patients During the First Year of Treatment5
Brain Radiotherapy Combined with Targeted Therapy for HER2-Positive Breast Cancer Patients with Brain Metastases4
Staging of the Axilla in Breast Cancer and the Evolving Role of Axillary Ultrasound4
<p>Intensity-Modulated Radiotherapy with Concomitant Boost After Breast Conserving Surgery: A Phase I–II Trial</p>4
Perceived Barriers and Facilitators to Breast Cancer Screening Among Women in Saudi Arabia4
Identifying Risk Factors of Breast Cancer Among Women Attending Selected Hospitals of Addis Ababa City: Hospital-Based Unmatched Case-Control Study4
A Cross-Sectional Evaluation of Knowledge About Breast Cancer and Perceived Barriers to the Uptake of Mammogram Screening Among Northern Saudi Women: A Population-Based Study4
Triple-Negative Breast Cancer: Assessing the Role of Immunohistochemical Biomarkers on Neoadjuvant Treatment4
TGF-β-Induced TMEPAI Promotes Epithelial–Mesenchymal Transition in Doxorubicin-Treated Triple-Negative Breast Cancer Cells via SMAD3 and PI3K/AKT Pathway Alteration4
Comparing the Gonadotoxicity of Multiple Breast Cancer Regimens: Important Understanding for Managing Breast Cancer in Pre-Menopausal Women4
Neu Perspectives, Therapies, and Challenges for Metastatic HER2-Positive Breast Cancer4
Economic Evaluation of Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer in the United States4
Androgen Receptor Status in Triple Negative Breast Cancer: Does It Correlate with Clinicopathological Characteristics?4
Assessment of Knowledge and Awareness About Breast Self-Examination Among University Female Students in Saudi Arabia4
Ribociclib in the Treatment of Hormone-Receptor Positive/HER2-Negative Advanced and Early Breast Cancer: Overview of Clinical Data and Patients Selection4
Clinical Characteristics and Survival Outcomes of Patients with De Novo Metastatic Breast Cancer3
Re-Evaluating the Association Between Hormonal Contraception and Breast Cancer Risk3
Chloride Intracellular Channel 1 is a Potential Biomarker for Breast Cancer3
Metformin Inducing the Change of Functional and Exhausted Phenotypic Tumor-Infiltrated Lymphocytes and the Correlation with JNK Signal Pathway in Triple-Negative Breast Cancer3
Breast Cancer Subtypes and Prognosis: Answers to Subgroup Classification Questions, Identifying the Worst Subgroup in Our Single-Center Series3
The Effect of Estrogen Receptor Status on Survival in Breast Cancer Patients in Ethiopia. Retrospective Cohort Study3
Differences in Treatment Outcomes Between Patients with HER2-Low versus HER2-Zero, Hormone Receptor-Positive Advanced-Stage Breast Cancer Treated with Ribociclib3
Cross-Platform in-silico Analyses Exploring Tumor Immune Microenvironment with Prognostic Value in Triple-Negative Breast Cancer3
FOXQ1 is Differentially Expressed Across Breast Cancer Subtypes with Low Expression Associated with Poor Overall Survival3
An Magnetic-Targeting Nano-Diagnosis and Treatment Platform for TNBC3
Drug-Resistant Breast Cancer: Dwelling the Hippo Pathway to Manage the Treatment3
Jawbone Cavitation Expressed RANTES/CCL5: Case Studies Linking Silent Inflammation in the Jawbone with Epistemology of Breast Cancer3
In vitro to Clinical Translation of Combinatorial Effects of Doxorubicin and Abemaciclib in Rb-Positive Triple Negative Breast Cancer: A Systems-Based Pharmacokinetic/Pharmacodynamic Modeling Approach3
A Scoping Review on the Status of Female Breast Cancer in Asia with a Special Focus on Nepal3
Breast Cancer Adjuvant Radiotherapy in BRCA1/2, TP53, ATM Genes Mutations: Are There Solved Issues?3
Optimized Radiomics Nomogram Based on Automated Breast Ultrasound System: A Potential Tool for Preoperative Prediction of Metastatic Lymph Node Burden in Breast Cancer3
Therapeutic Role of Annona muricata Fruit and Bee Venom Against MNU-Induced Breast Cancer in Pregnant Rats and its Complications on the Ovaries3
Association of Endocrine Therapy and Dementia in Women with Breast Cancer3
Thyroid Hormone Changes Correlate to Combined Breast Cancer with Primary Thyroid Cancer3
Role of Surgery in Metastatic Breast Cancer: Insights from a Narrative Review3
Disparities in Guideline-Concordant Initial Systemic Treatment in Women with HER2-Negative Metastatic Breast Cancer: A SEER-Medicare Analysis3
Immunotherapy: Constructive Approach for Breast Cancer Treatment3
The Notch Signaling Pathway Contributes to Angiogenesis and Tumor Immunity in Breast Cancer3
Breast Self-Examination Practice and Associated Factors Among Women Attending Family Planning Service in Modjo Public Health Facilities Southwest Ethiopia3
0.036744832992554